RPG Life Sciences Limited — Board Meeting, 28-04-2025: Outcome of Board Meeting

RPG Life Sciences has announced a board meeting outcome, approving the audited financial results for the quarter and year ended March 31, 2025, reflecting a profit of ₹11,735 crore. The board has approved a final dividend of ₹20 and a special dividend of ₹4 per equity share, pending shareholder approval. Ms. Vasundhara Patni has been appointed as an Additional Director, while Mr. Ashok Nair has resigned from senior management. Additionally, Mr. Yugal Sikri will transition to a Non-Executive Non-Independent Director role. M/s. Parikh Parekh & Associates will serve as Secretarial Auditors for five years.